Insider · CIK 0002108044
Bilal Arshad Khan
Files at SGP (SpyGlass Pharma, Inc.). First filing Feb 11, 2026, latest Feb 11, 2026.
In brief
Bilal Arshad Khan files SEC Form 4 as director at SGP (SpyGlass Pharma, Inc.). Since Feb 11, 2026, Bilal Arshad Khan has reported 1 open-market buy worth $2.2M and 0 open-market sells worth $0, the latest filed on Feb 11, 2026.
A track record needs three past buys with six months of prices behind them; Bilal Arshad Khan has 0, so none is measured yet.
The newest scored trade: bought $2.2M of SGP on Feb 9, 2026, filed Feb 11, 2026, scored 65 (notable). In the last 12 months: 1 buy worth $2.2M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SGP: SpyGlass Pharma, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 65Notable | SpyGlass Pharma, Inc. | $2.2M 135,000 shares | +2477% | - |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | POpen-market purchase Common Stock | +20,000 | $16.00 | $320k | 25,450 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | POpen-market purchase Common Stockindirect: See footnote | +115,000 | $16.00 | $1.8M | 251,427 | Feb 11, 2026 |
| Feb 5, 2026 | SGP SpyGlass Pharma, Inc. | AGrant or award Stock Option (right to buy)derivative | +13,700 | $0.00 | $0 | 13,700 | Feb 9, 2026 |
Questions about Bilal Arshad Khan
Answered from the filings on this page, as of the latest one.
Is Bilal Arshad Khan buying or selling?
In the last 12 months Bilal Arshad Khan reported 1 open-market buy worth $2.2M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $2.2M of SGP on Feb 9, 2026. Grants, option exercises and tax withholding are not counted.
How did Bilal Arshad Khan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bilal Arshad Khan has 0.
Where does Bilal Arshad Khan file Form 4?
Bilal Arshad Khan has filed Form 4 at SGP (SpyGlass Pharma, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.